Your browser doesn't support javascript.
loading
Outcomes of Ultrafiltration in community-based hospitals.
Chinta, Viswanath R; Theella, Neelima P; Raja, Joel M; Rawal, Aranyank; Bath, Anandbir; Jones, David; Ibrahim, Atif; Asbeutah, Abdul Aziz A; Adeboye, Adedayo A; Akbilgic, Oguz; Khouzam, Rami N; Stamper, James J; Jefferies, John L.
Affiliation
  • Chinta VR; Department of Advanced Heart Failure and Transplant Cardiology, HCA Houston HealthCare Medical Center, Houston, TX, USA. Electronic address: viswanath.chinta@hcahealthcare.com.
  • Theella NP; Department of Advanced Heart Failure and Transplant Cardiology, HCA Houston HealthCare Medical Center, Houston, TX, USA.
  • Raja JM; University of Tennessee Health Science Center, Memphis, TN, USA.
  • Rawal A; University of Tennessee Health Science Center, Memphis, TN, USA.
  • Bath A; Ascension Borgess Hospital/Michigan State University Kalamazoo, Michigan, USA.
  • Jones D; University of Tennessee Health Science Center, Memphis, TN, USA.
  • Ibrahim A; North Mississippi Medical Center, Tupelo, MS, USA.
  • Asbeutah AAA; University of Tennessee Health Science Center, Memphis, TN, USA.
  • Adeboye AA; University of Tennessee Health Science Center, Memphis, TN, USA.
  • Akbilgic O; Department of Cardiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Khouzam RN; Heart and Vascular institute, Grand Strand Medical Center, Myrtle Beach, SC, USA.
  • Stamper JJ; Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Jefferies JL; University of Memphis, Memphis, TN, USA.
Curr Probl Cardiol ; 49(10): 102716, 2024 Oct.
Article de En | MEDLINE | ID: mdl-38909929
ABSTRACT

OBJECTIVE:

We sought to examine outcomes of ultrafiltration in real world community-based hospital settings.

BACKGROUND:

Ultrafiltration (UF) is an accepted therapeutic option for advanced decompensated heart failure (ADHF). the feasibility of UF in a community hospital setting, by general cardiologists in a start-up program had not been objectively evaluated.

METHODS:

We retrospectively analyzed the first-year cohort of ADHF patients treated with UF from 10/1/2019 to 10/1/2020, which totaled 30 patients, utilizing the CHF Solutions Aquadex FlexFlow™ System with active UF rate titration.

RESULTS:

Baseline patient characteristics were similar to RCTs mean age 63, 73 % male; 27 % female; 53 % Caucasian; 47 % African American; 77 % had LVEF ≤ 40. The baseline mean serum creatinine (Cr) was 1.84 ±0.62 mg/dL, mean GFR of 36.95 ±9.60 ml/min. HF re-admission rates were not significantly different than prior studies (17.2 % at 30 d, 23.3 % at 60 d, but in our cohort, per patient HF re-admission rates were reduced significantly by 60 d (0.30 p = 0.017).

CONCLUSION:

Our analysis showed success with UF in mainstream setting with reproducible results of significant volume loss without adverse renal effect, mitigation of recurrent Hdmissions, and remarkable subjective clinical benefit.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ultrafiltration / Défaillance cardiaque / Hôpitaux communautaires Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Curr Probl Cardiol Année: 2024 Type de document: Article Pays de publication: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ultrafiltration / Défaillance cardiaque / Hôpitaux communautaires Limites: Aged / Female / Humans / Male / Middle aged Langue: En Journal: Curr Probl Cardiol Année: 2024 Type de document: Article Pays de publication: Pays-Bas